UNIVERSITY OF MINNESOTA
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (HISTO-FACT)
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (HISTO-FACT) is a funding opportunity from UNIVERSITY OF MINNESOTA, up to 870925, closing August 31, 2032.
Aug 31, 2032
(2223d left)Overview
Abstract Histoplasma capsulatum causes histoplasmosis, which is estimated to occur in ~500,000 persons per year in the U.S. alone and is most common cause of HIV-related mortality in Central and South America. While many cases are asymptomatic or mildly symptomatic, disseminated histoplasmosis (particularly in those…